Inter-operator variation in ELISPOT analysis of measles virus-specific IFN-γ-secreting T cells

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 65, Issue 8, 2005, Pages 681-690

  Ryan, J E ^a   Ovsyannikova, I G ^a   Dhiman, N ^a   Pinsky, N A ^a   Vierkant, R A ^a   Jacobson, R M ^a   Poland, G A ^a  

^a MAYO CLINIC   (United States)

Author keywords

Cytokines; IFN gamma; Measles virus; Measles mumps rubella vaccine

Indexed keywords

GAMMA INTERFERON; MEASLES MUMPS RUBELLA VACCINE;

ADULT; ANALYTIC METHOD; ANTIBODY SPECIFICITY; ARTICLE; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; ENZYME LINKED IMMUNOSPOT ASSAY; HUMAN; MEASLES; MEASLES VIRUS; MEMORY CELL; MUMPS; OBSERVER VARIATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RUBELLA; T LYMPHOCYTE ACTIVATION;

MEASLES VIRUS;

EID: 28744439520     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.1080/00365510500348252     Document Type: Article

References (32)

1. Czerkinsky CC, Nilsson LA, Nygren H, Ouchterlony O, Tarkowski A. A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. J Immunol Methods 1983;65:109-21.
2. Sedgwick JD, Holt PG. A solid-phase immunoenzymatic technique for the enumeration of specific antibody-secreting cells. J Immunol Methods 1983;57:301-9.
3. Czerkinsky C, Andersson G, Ekre HP, Nilsson LA, Klareskog L, Ouchterlony O. Reverse ELISPOT assay for clonal analysis of cytokine production. I. Enumeration of gamma-interferon-secreting cells. J Immunol Methods 1988;110:29-36.
4. Helms T, Boehm BO, Asaad RJ, Trezza RP, Lehmann PV, Tary-Lehmann M. Direct visualization of cytokine-producing recall antigen-specific CD4 memory T cells in healthy individuals and HIV patients. J Immunol 2000;164:3723-32.
5. Nanan R, Rauch A, Kämpgen E, Niewiesk S, Kreth HW. A novel sensitive approach for frequency analysis of measles virus-specific memory T-lymphocytes in healthy adults with a childhood history of natural measles. J Gen Virol 2000;81:1313-19.
6. Danke NA, Kwok WW. HLA class II-restricted CD4+ T cell responses directed against influenza viral antigens postinfluenza vaccination. J Immunol 2003;171:3163-9.
7. Bercovici N, Duffour MT, Agrawal S, Salcedo M, Abastado JP. New methods for assessing T-cell responses. Clin Diagn Lab Immunol 2000;7:859-64.
8. Carvalho LH, Hafalla JCR, Zavala F. ELISPOT assay to measure antigen-specific murine CD8+ T cell responses. J Immunol Methods 2001;252:207-18.
9. Ovsyannikova IG, Dhiman N, Jacobson RM, Vierkant RA, Poland GA. Frequency of measles virus-specific CD4+ and CD8+ T cells in subjects seronegative or highly seropositive for measles vaccine. Clin Diag Lab Immunol 2003;10:411-16.
10. Janetzki S, Schaed S, Blachere NE, Ben Porat L, Houghton AN, Panageas KS. Evaluation of Elispot assays: influence of method and operator on variability of results. J Immunol Methods 2004;291:175-83.
11. Ovsyannikova IG, Jacobson RM, Vierkant RA, Jacobsen SJ, Pankratz VS, Poland GA. The contribution of HLA class I antigens in immune status following two doses of rubella vaccination. Hum Immunol 2004;65:1506-15.
12. Dhiman N, Ovsyannikova IG, Howe RC, Ryan JE, Jacobson RM, Poland GA. Interleukin-4 induced by measles virus and measles-derived peptides as measured by IL-4 receptor-blocking ELISA. J Immunol Methods 2004;287:217-25.
13. Ryan JE, Ovsyannikova IG, Poland GA. Detection of measles virus-specific interferon-γ-secreting T-cells by ELISPOT. Methods Mol Biol 2005;302:207-18.
14. Boehm U, Klamp T, Groot M, Howard JC. Cellular responses to interferon-gamma. Annu Rev Immunol 1997;15:749-95.
15. Ward BJ, Boulianne N, Ratnam S, Guiot M-C, Couillard M, De Serres G. Cellular immunity in measles vaccine failure: demonstration of measles antigen-specific lymphoproliferative responses despite limited serum antibody production after revaccination. J Infect Dis 1995;172:1591-5.
16. Jaye A, Magnusen AF, Sadiq AD, Corrah T, Whittle HC. Ex vivo analysis of cytotoxic T lymphocytes to measles antigens during infection and after vaccination in Gambian children. J Clin Invest 1998;102:1969-77.
17. Gans H, Yasukawa L, Rinki M, et al. Immune responses to measles and mumps vaccination of infants at 6, 9, and 12 months. J Infect Dis 2001;184:817-26.
18. Pauksen K, Sjolin J, Linde A, et al. Th1 and Th2 cytokine responses after measles antigen stimulation in vitro in bone marrow transplant patients: response to measles vaccination. Bone Marrow Transplant 1997;20:317-23.
19. Smith JG, Liu X, Kaufhold RM, Clair J, Caulfield MJ. Development and validation of a gamma interferon elispot assay for quantitation of cellular immune responses to varicella-zoster virus. Clin Diagn Lab Immunol 2001;8:871-9.
20. Levin MJ, Smith JG, Kaufhold RM, et al. Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-hose VZV vaccine. J Infect Dis 2003;188:1336-44.
21. Ennis FA, Cruz J, Demkowicz WE Jr, Rothman AL, McClain DJ. Primary induction of human CD8+ cytotoxic T lymphocytes and interferon-g-producing T cells after smallpox vaccination. J Infect Dis 2002;185:1657-9.
22. Shata MT, Shan MM, Tricoche N, Talal A, Perkus M, Prince A. Optimization of recombinant vaccinia-based ELISPOT assay. J Immunol Methods 2003;283:281-9.
23. Zheng NN, Kiviat NB, Sow PS, et al. Comparison of human immunodeficiency virus (HIV)-specific T-cell responses in HIV-1- and HIV-2-infected individuals in Senegal. J Virol 2004;78:13934-42.
24. Jung M-C, Pape GR, Zachoval R, et al. Immunological monitoring during therapeutic vaccination as a prerequisite for the design of new effective therapies: induction of a vaccine-specific CD4+ T-cell proliferative response in chronic hepatitis B carriers. Vaccine 2002;20:3598-612.
25. Ouyang Q, Wagner WM, Wikby A, Remarque E, Pawelec G. Compromised interferon gamma (IFN-gamma) production in the elderly to both acute and latent viral antigen stimulation: contribution to the immune risk phenotype? Eur Cytokine Network 2002;13:392-4.
26. Ott PA, Berner BR, Herzog BA, et al. CD28 costimulation enhances the sensitivity of the ELISPOT assay for detection of antigen-specific memory effector CD4 and CD8 cell populations in human diseases. J Immunol Methods 2004;285:223-35.
27. Amrolia PJ, Muccioli-Casadei G, Yvon E, et al. Selective depletion of donor alloreactive T cells without loss of antiviral or antileukemic responses. Blood 2003;102:2292-9.
28. Sastry KJ, Nehete PN, Nehete B. Improving the sensitivity of the ELISPOT analyses of antigen-specific cellular immune responses in rhesus macaques. Methods Mol Biol 2005;302:153-66.
29. Chesler DA, Reiss CS. The role of IFN-gamma in immune responses to viral infections of the central nervous system. Cytokine Growth Factor Rev 2002;13:441-54.
30. Herr W, Linn B, Leister N, Wandel E, Meyer zum Buschenfelde K-H, Wolfel T. The use of computer-assisted video image analysis for the quantisation of CD8+ T lymphocytes producing tumor necrosis factor alpha spots in response to peptide antigens. J Immunol Methods 1997;203:141-52.
31. McCutcheon M, Wehner N, Wensky A, et al. A sensitive ELISPOT assay to detect low-frequency human T lymphocytes. J Immunol Methods 1997;210:149-66.
32. Hernandez-Fuentes MP, Warrens AN, Lechler RI. Immunologic monitoring. Immunol Rev 2003; 196:247-64.